Grant Description; Service Terms
The Grant consists of the performance by Sponsor, at no charge to the Recipient or its institution or company, of staining to analysis services for up to four (4) FFPE Human Tissue Samples (including xenograft) or Fresh Frozen Mouse Tissue on a CODEX® system on a pre-designed panel for immune profiling. The FFPE Human Tissue Immune Monitoring Panel comprises the following markers: CD4, CD68, CD20, CD11c, CD8, HLA-DR, CD3e, CD44, CD45, HLA-A, CD14, Ki67, Pan-Cytokeratin, CD57, CD45RO, CD163, CD19, FoxP3, Granzyme B, CD11b, CD21, SMA, Vimentin, CD34, Collagen IV. The Fresh Frozen Mouse Tissue Immune Monitoring Panel comprises the following markers: CD90, CD31, TCR, Ter119, CD44, CD45, CD19, CD169, CD45R/B220, MHCII, CD3, IgM, CD5, Ly6g, CD38, CD21/35, CD71, IgD, CD4, CD11c, CD24, CD8a, CD49f, CD11b, Ki67. Upon completion of such services, Sponsor will provide a report (in Sponsor’s standard format) with characterization and visualization data of the relevant tissue microenvironment. Approximate retail value of the Grant is $5,000.00 USD.
Receipt of the Grant by the Recipient is conditioned on compliance with any and all federal, state, and local laws and regulations. If the Recipient violates any of these terms and conditions, the Recipient (at Sponsor’s sole discretion) will be disqualified, and any and all privileges as the Recipient will immediately terminate.
As a condition to receiving the Grant, the Recipient’s institution or company must agree in writing to Sponsor’s standard terms and conditions for the applicable staining to analysis services, which set forth, among other things, requirements for samples, sequencing data or other information or materials to be provided to Sponsor, Sponsor’s right to use data resulting from the services for product development purposes and in marketing or informational materials (and to indicate in connection with such materials that such data were generated in collaboration with Recipient and its institution or company), and limitations on Sponsor’s liability (“Service Terms”). If the Recipient’s institution or company fails to agree in writing to the Service Terms, the Grant may be forfeited and an alternate Recipient may be selected, based on the criteria set forth above, in the sole discretion of Sponsor. Recipient shall ensure that all tissue samples, sequencing data and other information and materials to be provided to Sponsor under the Service Terms are provided to Sponsor no later than January 1, 2022 (unless otherwise agreed by Sponsor).